Clinical Trials Logo

Filter by:
NCT ID: NCT02989129 Withdrawn - Clinical trials for Chemotherapy Induced Neuropathic Pain

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

Start date: April 2018
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical research study is to learn about the effectiveness of quercetin in treating and preventing CINP. Researchers also want to learn if quercetin has an effect on participant's quality of life.

NCT ID: NCT03069768 Withdrawn - Nicotine Dependence Clinical Trials

Stage Ib Trial of mSMART With Varenicline

mSMART-v
Start date: April 2018
Phase: Phase 1
Study type: Interventional

The primary aim of this study is to conduct a 60-patient feasibility, acceptability, and preliminary efficacy study of mSMART (Mobile App based Personalized Solutions and Tools for Medication Adherence of Rx Pill), a smartphone application ("app") for improving medication adherence among substance users. The investigators will compare 2 groups of cigarette smokers undergoing a quit attempt with varenicline (Chantix): a) an experimental group using the mSMART app on their smartphone and a MEMS Cap (Medication Event Monitoring System, a smart pillbox that will a record a date and time-stamped medication event whenever pill box is opened and closed, and thus allow for primary measurement of medication adherence) and b) a control group using the MEMS Cap and mobile web-based surveys on their smartphone.

NCT ID: NCT03123315 Withdrawn - Hysterectomy Clinical Trials

Optimization of Ureterolysis During Hysterectomy

Start date: April 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to improve the safety of surgery to remove a uterus (a hysterectomy) by better understanding where a patient's ureters lie.

NCT ID: NCT03173794 Withdrawn - Clinical trials for Patient Satisfaction

CommunityRx for Hunger: A Hospital-Based Intervention

Start date: April 2018
Phase: N/A
Study type: Interventional

The goal of this research program is to reduce health disparities by deploying an information-based intervention to increase caregiver utilization of community-based food supports and satisfaction with care among food insecure caregivers of hospitalized children. We will conduct a randomized controlled trial to evaluate, versus usual care, the effects of the CommunityRx-H intervention on caregiver use of food resources (primary), caregiver patient satisfaction with care (primary), caregiver mental health-related quality of life (secondary), and caregiver household food security (secondary). The proposed research will yield an understanding of how to leverage a child's hospitalization to effectively intervene on the problem of food insecurity. Findings will inform the rapidly growing field of healthcare-based interventions to address health-related social needs.

NCT ID: NCT03187899 Withdrawn - Pain, Postoperative Clinical Trials

Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia

Start date: April 2018
Phase: Phase 3
Study type: Interventional

The goal of the study is to determine if the addition of a superficial cervical plexus block to a traditional interscalene plexus block will provide superior perioperative analgesia to an interscalene brachial plexus blockade alone for repair of clavicle fractures and non-/malunions.

NCT ID: NCT03191487 Withdrawn - Clinical trials for Colorectal Neoplasms

Evaluation of a New Organization for Collecting Pre-chemotherapy Session Information

ChimioPal
Start date: April 2018
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare an experimental organization for chemotherapy session planning based on early, standardized, and prioritized means of data transmission via secure e-mail (laboratory results) and the use of a smart phone (for clinical toxicity data) compared to the regular organization, in terms of the rate of prescriptions of chemotherapy prepared at the latest the day before a session and then administered in full (over a 6-month observation period) among colorectal cancer patients in need of cancer treatment in an outpatient setting.

NCT ID: NCT03237897 Withdrawn - Colorectal Surgery Clinical Trials

Evaluation of a Preoperative Education Class for Colorectal Surgery Patients

Start date: April 2018
Phase:
Study type: Observational

The purpose of the study is to evaluate the value and effectiveness of a newly-implemented preoperative education class for patients undergoing colorectal surgery.

NCT ID: NCT03251586 Withdrawn - Clinical trials for Vestibular Abnormality

Test-Retest Reliability of oVEMP's Across Different Electrode Montages

Start date: April 2018
Phase: N/A
Study type: Interventional

"Test-Retest Reliability of ocular vestibular evoked myogenic potentials (oVEMPs) across different electrode montages." The purpose of this project is to compare the response characteristics of the ocular vestibular evoked myogenic potential in patients grouped by decade (i.e. 20's-90's) using two different recording montages and two different stimulus types (i.e. air and bone conducted sound). The long-term goal is to increase the sensitivity and specificity of the oVEMP when used clinically to identify vestibular disorders affecting the utricle and superior portion of the vestibular nerve.

NCT ID: NCT03291158 Withdrawn - Clinical trials for Normal Healthy Volunteers

Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV

Start date: April 2018
Phase: Phase 1
Study type: Interventional

This is a phase 1, safety and PK Open-Label trial evaluating the plasma, epithelial lining fluid, and alveolar macrophage concentrations of intravenous Minocin® (Minocycline) for injection in healthy adult subjects.

NCT ID: NCT03347994 Withdrawn - Clinical trials for Acute Myeloid Leukemia

Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Start date: April 2018
Phase: Phase 1
Study type: Interventional

Minnelide, a water-soluble disodium salt variant of triptolide, is a diterpenoid heat shock protein 70 (HSP70) inhibitor. Studies using AML cell lines, primary patient samples, and mouse transplant models demonstrate that Minnelide has potent cell killing effects. Minnelide has already been developed for human use and given to patients in a phase I trial for gastrointestinal (GI) cancers. Given the clinical safety profile and preliminary activity described in human GI cancers, the low-nanomolar anti-leukemic potency of triptolide in vitro, and that minnelide doses predicted to be significantly below the maximum tolerated dose (MTD) in human GI cancers decreased leukemia burden in animal models, the investigators propose a phase I trial in acute myeloid leukemia (AML).